Horizon Discovery Group (HZD)
HZD Share PerformanceMore
|52 week high||222.00 25/05/17|
|52 week low||104.00 30/11/16|
|52 week change||42.00 (24.21%)|
|4 week volume||1,877,033 01/05/17|
Media for (HZD)
Latest News« previous» nextMore
22/05/2017 - 09:40 StockMarketWire
Horizon Discovery Group has gained exclusive worldwide rights to use a novel transposon-based technology platform whi...
22/05/2017 - 07:00 RNS
RNS Number: 7404F Horizon Discovery Group plc 22 May 2017 Horizon Discovery Announces New Gene Editing Technology Platform for Research and Therapeutic Applications Technology provides a unique approach to gene editing and DNA delivery Enables Horizon to use gene editing directly as a therapeutic Immediate applications in biomanufacturing, diagn...
09/05/2017 - 07:00 RNS
RNS Number: 5315E Horizon Discovery Group plc 09 May 2017 Horizon Discovery Announces Update on its Immuno-Oncology Platform including Strong Uptake of Product and Service Offerings Over 1.5 million in current and ongoing contract research services, product sales, and R&D collaboration payments have been derived from platform in FY17 to date, repr...
25/04/2017 - 07:14 RNS
RNS Number: 2190D Horizon Discovery Group plc 25 April 2017 25 April 2017 Horizon Discovery Group plc Additional Listing The Company has issued and allotted 186,500 new ordinary shares of 1p each pursuant to the exercise of options. Accordingly, an application has been made for 186,500 new ordinary shares to be admitted to trading on AIM and it is expected ...
21/04/2017 - 07:00 RNS
RNS Number: 9571C Horizon Discovery Group plc 21 April 2017 21 April 2017 Horizon Discovery Group plc Additional Listing The Company has issued and allotted 100,000 new ordinary shares of 1p each pursuant to the exercise of options. Accordingly, an application has been made for 100,000 new ordinary shares to be admitted to trading on AIM and it is expected t...
19/04/2017 - 07:00 RNS
RNS Number: 6395C Horizon Discovery Group plc 19 April 2017 HORIZON DISCOVERY GROUP PLC ("Horizon" or "the Company") Notice of Preliminary Results Cambridge, UK, 19 April 2017: Horizon Discovery Group plc (LSE: HZD) (Horizon),the world leader in the application of gene editing technologies , announces today that its preliminary results for the t...
11/04/2017 - 14:57 RNS
RNS Number: 2302C Horizon Discovery Group plc 11 April 2017 For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Horizon Discovery Group Plc 2 Reason for the notif...
07/04/2017 - 17:01 RNS
RNS Number: 9834B Horizon Discovery Group plc 07 April 2017 Grant of options under the Horizon Discovery Group plc Long Term Incentive Plan (the "LTIP") Cambridge, UK, 7 April 2017: Horizon Discovery Group plc (LSE: HZD), the world leader in the application of gene editing technologies, announces that the following options were granted today over the Co...
|Dividend yield||0 %|
Latest discussion posts More
“4 dir + 100,000. Dr Johnathan Milner non ex +90,000. Founder of Abacam & Pharma superstar. Woodford also a holder”▼
“From Citywire: "?Biologic? era benefits Horizon Discovery, says Numis Gene-editing company Horizon Discovery (HZDH) has improved efficiency and is driving its product ...”▼
“"An announcement this morning sees Horizon expand the application of its bioproduction cell line platform with new partnerships with the Centre for Process Innovation (CPI, UK) ...”▼
Codes & Symbols
|Symbols||HZD, LSE:HZD, HZD.L, HZD:LN, LON:HZD, XLON:HZD|